AASLD has always put the patient first by providing clinicians with the latest rigorous data on the best treatments for patients with liver diseases, including hepatitis C.
Public policy issues having a direct impact on the discipline are actively monitored and communicated by the Public Policy Committee, which is making recommendations to influence issues as they are raised in the nation's capital.
The following articles were written by Lyle Dennis, of Cavarocchi – Ruscio – Dennis Associates. They are policy consultants to AASLD.
AASLD Deepens Its Relationship with Patient Groups
December 4, 2018
What Lies Ahead for Government Funding?
October 30, 2018
Congress Comes Back …To Look for the Exits
No Sooner is FY18 Put to Rest …
Keeping Our Eyes on the Prize
Wednesday, April 18 – Mark it down!